Skip to main content
. 2012 May 7;17(5):694–707. doi: 10.1634/theoncologist.2011-0341

Table 4.

Proteasome inhibitor combination regimens evaluated in the treatment of DLBCL

graphic file with name onc00512-1050-t04.jpg

Abbreviations: CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone; DLBCL, diffuse large B-cell lymphoma; EPOCH, cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide; R-CHOP, rituximab plus CHOP.